Adaptive Biotechnologies Corp Stock Market Value
| ADPT Stock | USD 5.73 0.05 0.88% |
| Symbol | Adaptive |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adaptive Biotechnologies. If investors know Adaptive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adaptive Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Adaptive Biotechnologies is measured differently than its book value, which is the value of Adaptive that is recorded on the company's balance sheet. Investors also form their own opinion of Adaptive Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adaptive Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adaptive Biotechnologies' market value can be influenced by many factors that don't directly affect Adaptive Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adaptive Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adaptive Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adaptive Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Adaptive Biotechnologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Adaptive Biotechnologies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Adaptive Biotechnologies.
| 08/31/2024 |
| 11/29/2024 |
If you would invest 0.00 in Adaptive Biotechnologies on August 31, 2024 and sell it all today you would earn a total of 0.00 from holding Adaptive Biotechnologies Corp or generate 0.0% return on investment in Adaptive Biotechnologies over 90 days. Adaptive Biotechnologies is related to or competes with Verve Therapeutics, Beam Therapeutics, Caribou Biosciences, Sana Biotechnology, Royalty Pharma, Ikena Oncology, and Hepion Pharmaceuticals. Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis... More
Adaptive Biotechnologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Adaptive Biotechnologies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Adaptive Biotechnologies Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.02 | |||
| Information Ratio | 0.0591 | |||
| Maximum Drawdown | 31.46 | |||
| Value At Risk | (7.87) | |||
| Potential Upside | 9.71 |
Adaptive Biotechnologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Adaptive Biotechnologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Adaptive Biotechnologies' standard deviation. In reality, there are many statistical measures that can use Adaptive Biotechnologies historical prices to predict the future Adaptive Biotechnologies' volatility.| Risk Adjusted Performance | 0.071 | |||
| Jensen Alpha | 0.4592 | |||
| Total Risk Alpha | (0.40) | |||
| Sortino Ratio | 0.0823 | |||
| Treynor Ratio | (4.05) |
Adaptive Biotechnologies Backtested Returns
Adaptive Biotechnologies appears to be unstable, given 3 months investment horizon. Adaptive Biotechnologies secures Sharpe Ratio (or Efficiency) of 0.0952, which signifies that the company had a 0.0952% return per unit of standard deviation over the last 3 months. By analyzing Adaptive Biotechnologies' technical indicators, you can evaluate if the expected return of 0.53% is justified by implied risk. Please makes use of Adaptive Biotechnologies' risk adjusted performance of 0.071, and Mean Deviation of 3.84 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Adaptive Biotechnologies holds a performance score of 7. The firm shows a Beta (market volatility) of -0.11, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Adaptive Biotechnologies are expected to decrease at a much lower rate. During the bear market, Adaptive Biotechnologies is likely to outperform the market. Please check Adaptive Biotechnologies' coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Adaptive Biotechnologies' price patterns will revert.
Auto-correlation | 0.21 |
Weak predictability
Adaptive Biotechnologies Corp has weak predictability. Overlapping area represents the amount of predictability between Adaptive Biotechnologies time series from 31st of August 2024 to 15th of October 2024 and 15th of October 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Adaptive Biotechnologies price movement. The serial correlation of 0.21 indicates that over 21.0% of current Adaptive Biotechnologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.21 | |
| Spearman Rank Test | 0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 0.31 |
Adaptive Biotechnologies lagged returns against current returns
Autocorrelation, which is Adaptive Biotechnologies stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Adaptive Biotechnologies' stock expected returns. We can calculate the autocorrelation of Adaptive Biotechnologies returns to help us make a trade decision. For example, suppose you find that Adaptive Biotechnologies has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Adaptive Biotechnologies regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Adaptive Biotechnologies stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Adaptive Biotechnologies stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Adaptive Biotechnologies stock over time.
Current vs Lagged Prices |
| Timeline |
Adaptive Biotechnologies Lagged Returns
When evaluating Adaptive Biotechnologies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Adaptive Biotechnologies stock have on its future price. Adaptive Biotechnologies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Adaptive Biotechnologies autocorrelation shows the relationship between Adaptive Biotechnologies stock current value and its past values and can show if there is a momentum factor associated with investing in Adaptive Biotechnologies Corp.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Adaptive Stock Analysis
When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.